PubHawk
Ann Cardiothorac Surg July 2018 PMID 30094211

SYNTAX II and SYNTAX III trials: what is the take home message for surgeons?

Rodrigo Modolo, Carlos Collet, Yoshinobu Onuma, Patrick W Serruys

Full text PDF Download social card

Mentions

3
Peak: 1 in May 2020
across 2 sources since May 2020

Extended reach

2,443
potential audience

Total likes

19

Video views

2,040

Mentions per month

May 2020 – Jan 2022

Where it's discussed

  • YouTube2 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

Discussions highlight the relevance of the SYNTAX II and III trials in shaping modern coronary artery disease treatment, with phrases like 'current best practices' and 'shift towards personalized decision-making' emphasizing their significance. Posts reference the comparative benefits of advanced imaging and team-based approaches, demonstrating a strong interest in how these trials could change surgical paradigms.

AgreementModerate agreement

Most discussions acknowledge the importance of the trials for current surgical practices, though some express cautious optimism.

InterestModerate interest

Participants show moderate interest, emphasizing key points like the role of advanced diagnostic tools and team decision-making.

EngagementHigh engagement

Many posts delve into specific aspects of the trials, debating methodologies and implications, indicating deep engagement.

ImpactModerate impact

Users believe the findings could influence future clinical approaches, though some view it as incremental rather than revolutionary.

Abstract in brief

  • The SYNTAX II trial compares modern PCI techniques with the original SYNTAX trial outcomes, providing insights into current best practices for treating coronary artery disease (CAD).
  • The SYNTAX III trial focuses on how heart teams choose treatments for complex CAD by using either advanced imaging and physiological assessments or traditional angiography, highlighting a shift towards personalized decision-making.
  • Overall, these trials suggest that contemporary PCI methods are continually improving and that surgeon decision-making may increasingly rely on advanced diagnostic tools and a team-based approach in the future.
Read the full abstract

Top posts

Most liked on X and Bluesky
GeoScience.net
@GeoSciences · X

SYNTAX II and SYNTAX III trials: what is the take home message for surgeons? https://t.co/e6d3OwHyGL

Jan 16, 2022 · 404 followers View post →

All mentions

GeoScience.net
@GeoSciences · X

SYNTAX II and SYNTAX III trials: what is the take home message for surgeons? https://t.co/e6d3OwHyGL

Jan 16, 2022 · 404 followers View post →